Atherosclerosis and Lipoproteins |
and Interleukin-1ß
From the University of California, San Diego, La Jolla, Calif. Dr Kim is now at the Division of Cardiology, Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea.
Correspondence to Daniel Steinberg, MD, PhD, Department of Medicine 0682, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA 92093. E-mail dsteinberg{at}ucsd.edu
AbstractThe critical role of
monocyte recruitment in atherogenesis has been appreciated for some
time. However, until recently, there have been no sufficiently
sensitive methods for measuring rates of monocyte recruitment to the
arterial wall in vivo. We have developed a novel highly
sensitive method, based on the polymerase chain reaction, for
quantitatively tracking DNA-marked monocytes and have adapted it for
use in mice. We use the uniquely male gene, Sry, on the
Y chromosome as a gene marker. We transfuse monocytes from a male donor
into a congenic female mouse, euthanize the mouse after 24 to 48 hours,
and then quantify the arterial uptake of monocytes by
quantitative polymerase chain reaction. This study describes the
techniques used and their sensitivity and reproducibility and
demonstrates the approach by assessing the effects of
cytokines. In control low density lipoprotein
receptornegative mice, monocyte recruitment decreased slightly but
significantly as lesions progressed.
Intraperitoneal injection of a combination of tumor
necrosis factor-
and interleukin-1ß more than doubled the rate of
monocyte recruitment into developing lesions. However, the response to
the cytokines was much greater in younger mice with less
advanced lesions than in older animals with more advanced lesions.
Key Words: tumor necrosis factor-
interleukin-1ß monocytes atherogenesis
This article has been cited by other articles:
![]() |
M. F. Kircher, J. Grimm, F. K. Swirski, P. Libby, R. E. Gerszten, J. R. Allport, and R. Weissleder Noninvasive In Vivo Imaging of Monocyte Trafficking to Atherosclerotic Lesions Circulation, January 22, 2008; 117(3): 388 - 395. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Swirski, M. J. Pittet, M. F. Kircher, E. Aikawa, F. A. Jaffer, P. Libby, and R. Weissleder Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease PNAS, July 5, 2006; 103(27): 10340 - 10345. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Choudhury, J. X. Rong, E. Trogan, V. I. Elmalem, H. M. Dansky, J. L. Breslow, J. L. Witztum, J. T. Fallon, and E. A. Fisher High-Density Lipoproteins Retard the Progression of Atherosclerosis and Favorably Remodel Lesions Without Suppressing Indices of Inflammation or Oxidation Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1904 - 1909. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Portugal, L. R. Fernandes, G. C. Cesar, H. C. Santiago, D. R. Oliveira, N. M. Silva, A. A. Silva, J. Lannes-Vieira, R. M. E. Arantes, R. T. Gazzinelli, et al. Infection with Toxoplasma gondii Increases Atherosclerotic Lesion in ApoE-Deficient Mice Infect. Immun., June 1, 2004; 72(6): 3571 - 3576. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Litovsky, M. Madjid, A. Zarrabi, S. W. Casscells, J. T. Willerson, and M. Naghavi Superparamagnetic Iron Oxide-Based Method for Quantifying Recruitment of Monocytes to Mouse Atherosclerotic Lesions In Vivo: Enhancement by Tissue Necrosis Factor-{alpha}, Interleukin-1{beta}, and Interferon-{gamma} Circulation, March 25, 2003; 107(11): 1545 - 1549. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Van Lenten, A. C. Wagner, G.M. Anantharamaiah, D. W. Garber, M. C. Fishbein, L. Adhikary, D. P. Nayak, S. Hama, M. Navab, and A. M. Fogelman Influenza Infection Promotes Macrophage Traffic Into Arteries of Mice That Is Prevented by D-4F, an Apolipoprotein A-I Mimetic Peptide Circulation, August 27, 2002; 106(9): 1127 - 1132. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Lessner, H. L. Prado, E. K. Waller, and Z. S. Galis Atherosclerotic Lesions Grow Through Recruitment and Proliferation of Circulating Monocytes in a Murine Model Am. J. Pathol., June 1, 2002; 160(6): 2145 - 2155. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bobik and N. Kalinina Tumor Necrosis Factor Receptor and Ligand Superfamily Family Members TNFRSF14 and LIGHT: New Players in Human Atherogenesis Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 1873 - 1875. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |